Skip to content
TheChatArchiveThe Chat Archive
gpt-3.5-turbo-0613· OpenAIAi2 WildChat-4.8M (AI2)

improve:To comprehensively capitalize on the potential of IL-10 gene treatment in…

  1. User

    improve:To comprehensively capitalize on the potential of IL-10 gene treatment in promoting fibrosis improvement, further investigations were conducted to elucidate the underlying mechanisms. The production of cytokine IFN-γ by NK cells is directly correlated with their cytotoxicity to effectively eliminate target cells. Flow cytometry chart reveals that activated NK cells in the fibrotic liver exhibit higher levels of IFN-γ secretion compared to normal mice. Furthermore, IL-10 gene treatment resulted in a further augmentation of IFN-γ production by NK cells. The expression level of CD107a, a sensitive marker indicative of NK cell activity, is prominently elevated in fibrotic mice. Importantly, the flow cytometry chart demonstrates a further augmentation of CD107a expression in fibrotic mice treated with IL-10 gene therapy. These findings collectively suggest that IL-10 gene treatment can effectively enhance NK cell cytotoxicity in fibrotic mice. In addition, the cytotoxicity of NK cells is closely related to their developmental level. Observe the proportion of NK cells at three different maturity levels: immature (CD27+CD11b -), developing (CD27+CD11b+), and mature (CD27 CD11b+NK cells). The results showed that compared with fibrotic control mice, the number of developing NK cells with stronger ability to secrete cytokines and toxicity in the liver of fibrotic mice treated with IL-10 gene therapy significantly increased (Figure 4A). These findings collectively suggest that IL-10 gene treatment can effectively enhance NK cell cytotoxicity in fibrotic mice

  2. Assistant

    To fully exploit the potential of IL-10 gene therapy in promoting fibrosis improvement, extensive investigations were carried out to uncover the underlying mechanisms.

    One crucial aspect of NK cell activity is the production of the cytokine IFN-γ, which directly correlates with their ability to effectively eliminate target cells. Analysis of flow cytometry data reveals that activated NK cells in the fibrotic liver exhibit significantly higher levels of IFN-γ secretion compared to normal mice. Moreover, the administration of IL-10 gene therapy further enhances IFN-γ production by NK cells.

    Another key marker indicative of NK cell activity is CD107a, which is prominently elevated in fibrotic mice. Importantly, the flow cytometry chart demonstrates a further increase in CD107a expression in fibrotic mice treated with IL-10 gene therapy. These findings collectively suggest that IL-10 gene treatment effectively enhances the cytotoxicity of NK cells in fibrotic mice.

    Additionally, the cytotoxicity of NK cells is closely tied to their developmental stage. Therefore, the proportions of NK cells at three distinct maturity levels were examined: immature (CD27+CD11b-), developing (CD27+CD11b+), and mature (CD27+CD11b+NK cells). The results demonstrate that compared to fibrotic control mice, the number of developing NK cells with a greater ability to secrete cytokines and exert toxicity in the liver significantly increases in fibrotic mice treated with IL-10 gene therapy (Figure 4A).

    Taken together, these findings provide strong evidence that IL-10 gene treatment effectively enhances the cytotoxicity of NK cells in fibrotic mice.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.